Welcome to BioMarket Group!

eHealth Regulations in Europe: Understanding the Changing European Legislative Landscape

Additional Information

Published Date Apr 20, 2004
Special Offer No
Pages 49
PDF Fact Sheet View Fact Sheet for the report eHealth Regulations in Europe: Understanding the Changing European Legislative Landscape in PDF format.
Published on Date No
Format No
Publisher Datamonitor
Product Line No
Full Title eHealth Regulations in Europe: Understanding the Changing European Legislative Landscape

Availability: In stock

$3,800.00

Quick Overview

The coming year will be one of immense change for the pharmaceutical industry in Europe. The continued development of the eEconomy is critical to the continued growth and success of the European pharmaceutical market. Companies that implement forward-looking strategies will be able to hasten compliance and take full advantage of the opportunities presented by future regulations.
Request free sample pages from eHealth Regulations in Europe: Understanding the Changing European Legislative Landscape

Introduction

The coming year will be one of immense change for the pharmaceutical industry in Europe. The continued development of the eEconomy is critical to the continued growth and success of the European pharmaceutical market. Companies that implement forward-looking strategies will be able to hasten compliance and take full advantage of the opportunities presented by future regulations.

Scope

  • Analyzes the changing eHealth regulatory environment in Europe, including general strategies for successful compliance
  • Defines six key criteria outlined by the European Commission that attempt to address the quality issues specific to health-related websites
  • Assesses the current status of European data protection and data sharing initiatives
  • Explores the new clinical trials directive (Directive 2001/20/EC), including practical compliance solutions that can be used to ease the transition

Highlights

It is unlikely that direct-to-consumer advertising will be permitted in Europe in the near future. Pharmaceutical companies should develop other means of reaching their consumers, such as educational websites. Companies that develop websites according to defined quality criteria will foster consumer confidence and brand loyalty.

The European Union is developing increased public and private interoperability initiatives. With enhanced interoperability comes an increase in security risks associated with data sharing. Companies can prepare for the future by examining consumer information collection practices and reviewing their internal security policies.

Achieving compliance with the new clinical trials directive by the May 2004 deadline will be a challenge for the pharmaceutical industry. However, there are many compliance solutions that can be employed to ease the transition. Continued compliance will make it possible to develop better therapies by expediting the progress of products to market.

Reasons to Purchase

  • Understand the current and prospective eHealth market in Europe and where the key opportunities for your company lie
  • Bolster your company’s online market presence within Europe by providing comprehensive, accurate and reliable health-related information online
  • Take full advantage of the opportunities presented by future regulations and hasten compliance by developing forward-looking eHealth strategies
Request free sample pages from eHealth Regulations in Europe: Understanding the Changing European Legislative Landscape

Other selected research from the 'Europe' category:


Website Benchmarking Service: European and US Targeted Websites
Time constraints are limiting the amount of time that physicians and consumers spend to search for information, as well as the amount of time that pharmaceutical companies have to access physicians. As a result, the importance of pharmaceutical websites is growing. This tool looks at the success factors for the physician- and consumer-targeted websites of the top 20 pharmaceutical companies. Learn More


Website Benchmarking Tool: European Healthcare Professional and Consumer Targeted Websites
The number of product information sites provided to consumers in the EU is limited, while disease and public education sites are abundant and are used to effectively target consumers, and sites targeting healthcare professionals in the EU are readily available. Sites must be optimized to of influence their target audiences, and to attract, convert and retain these important decision makers. Learn More

Other selected research from the 'IT & eHealth' category:


The eHealth Market in the US: Assessing the Online Needs of Physicians and Consumers
The eHealth market in the US is generally more developed than that in Europe. Substantial investment from the government and the pharmaceutical industry has propelled the developments in initiatives such as online continuing medical education. There appears to be significant potential for further uptake of online services, most notably in the areas of eDetailing, eSampling and online CME. Learn More


The eHealth Market in France: Assessing the Online Needs of Physicians and Consumers
The eHealth market in France, driven by patients` and physicians` demands for online services, will provide opportunities for pharmaceutical companies to reach physicians and patients through online channels. In particular, Datamonitor finds potential for near-term growth in the eCompliance and eCME markets, and for long-term growth in the ePrescribing and eSampling markets. Learn More

Other selected research from the 'Regulation & Policy' category:


The Medical Device Outlook in Emerging Markets: The role of healthcare and regulatory systems in presenting challenges and growth opportunities
The emerging economies of Brazil, Russia, India, and China (BRIC) have become lucrative, high-growth markets for medical devices. The device market in developed territories such as the US, Europe... Learn More


Pharmacovigilance and Other Pharma Regulatory Developments 2010-2020
What will this decade hold for pharma regulatory affairs?

What regulatory demands will pharma companies face from 2010 to 2020? Our new study will show you developments in pharma regulations...
Learn More